ARNA Genomics

company

About

ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technology.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$3.50M
Industries
Biotechnology,Health Care,Health Diagnostics,Life Science,Medical
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technologies. The company is driven by a mission to save lives from cancer by giving people early diagnosis when cancer can be cured. Its genetic test is based on the analysis of free-circulating DNA in blood plasma and fluid biopsy technologies, enabling doctors to do early diagnosis and treatment initiation for cancer.

The company was founded in 2013 and is headquartered in Moscow City.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3.50M
ARNA Genomics has raised a total of $3.50M in funding over 2 rounds. Their latest funding was raised on Sep 21, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 21, 2020 Series A $3.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
ARNA Genomics is funded by 1 investors. Iskra Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Iskra Ventures Series A